Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 524-530

  Zhou, Juan ^a   Lv, Ruixue ^a   Song, Xingbo ^a   Li, Dongdong ^a   Hu, Xin ^b   Ying, Binwu ^a   Wei, Yonggang ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE SYNTHASE; HEPATITIS B SURFACE ANTIGEN; MICRORNA; MICRORNA 146A; MICRORNA 499; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALBUMIN BLOOD LEVEL; ALLELE; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHINA; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MICRORNAS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859741447     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1340     Document Type: Article

References (46)

1. Akao, Y., Nakagawa, Y., and Naoe, T. (2006). MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16, 845-850.
2. Akao, Y., Nakagawa, Y., and Naoe, T. (2007). MicroRNA-143 and - 145 in colon cancer. DNA Cell Biol 26, 311-320.
3. Ambros, V. (2003). MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113, 673-676.
4. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
5. Bandrés, E., Cubedo, E., Agirre, X., et al. (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and nontumoral tissues. Mol Cancer 5, 29.
6. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
7. Bartels, C.L., and Tsongalis, G.J. (2009). MicroRNAs: novel biomarkers for human cancer. Clin Chem 55, 623-631.
8. Cai, Y., Yu, X., Hu, S., et al. (2009). A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform 7, 147-154.
9. Calin, G.A., Cimmino, A., Fabbri, M., et al. (2008). MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 105, 5166-5171.
10. Chan, J.A., Krichevsky, A.M., and Kosik, K.S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65, 6029-6033.
11. Duan, R., Pak, C., Jin, P., et al. (2007). Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16, 1124-1131.
12. El-Serag, H.B., Rudolph, K.L., et al. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576.
13. Farazi, T.A., Spitzer, J.I., Morozov, P., et al. (2011). MiRNA in human cancer. J Pathol 223, 102-115.
14. Georges, M., Coppieters, W., and Charlie, C. (2007). Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 17, 166-176.
15. Hagymási, K., and Tulassay, Z. (2008). Epidemiology, risk factors and molecular pathogenesis of primary liver cancer. Orv Hetil 149, 541-548.
16. He, H., Jazdzewski, K., Li, W., et al. (2005). The role of micro-RNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102, 19075-19080.
17. Hu, Z., Chen, J., Tian, T., et al. (2008). Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118, 2600-2608.
18. Hu, Z.B., Liang, J., Wang, Z.W., et al. (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30, 79-84.
19. Huang, S., and He, X. (2011). The role of microRNAs in liver cancer progression. Br J Cancer 104, 235-240.
20. Iorio, M.V., Ferracin, M., Liu, C.G., et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65, 7065-7070.
21. Jazdzewski, K., Murray, E.L., Franssila, K. et al. (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105, 7269-7274.
22. Jazdzewski, K., Liyanarachchia, S., Swierniakb, M., et al. (2009). Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A 106, 1502-1505.
23. Jemal, A., Bray, F., Center, M.M., et al. (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
24. Johnson, C.D., Esquela-Kerscher, A., Stefani, G., et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67, 7713-7722.
25. Li, X.D., Li, Z.G., Song, X.X., et al. (2010a). A variant in micro-RNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42, 669-673.
26. Li, Y., Vandenboom, T.G., II, Wang, Z., et al. (2010b). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70, 1486-1495.
27. Ludwig, J.A., and Weinstein, J.N. (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5, 845-856.
28. Medina, P.P., Nolde, M., and Slack, F.J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90.
29. Pallante, P., Visone, R., Ferracin, M., et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13, 497-508.
30. Pastrello, C., Polesel, J., Della, P.L., et al. (2010). Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31, 2124-2126.
31. Peng, S., Kuang, Z.S., Sheng, C.Y., et al. (2009). Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55, 2288-2293.
32. Qi, P., Dou, T.H., Geng, L., et al. (2010). Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71, 621-626.
33. Shen, J., Ambrosone, C.B., DiCioccio1, R.A., et al. (2008). A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29, 1963-1966.
34. Thorgeirsson, S.S., and Grisham, J.W. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31, 339-346.
35. Volinia, S., Calin, G.A., Liu, C.G., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103, 2257-2261.
36. Wang, J.X., Jiao, J.Q., Li, Q., et al. (2011). miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynaminrelated protein-1. Nat Med 17, 71-78.
37. Wilson, K.D., Hu, S., Venkatasubrahmanyam, S., et al. (2010). Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 3, 426-435.
38. Xu, T., Zhu, Y., Wei, Q.K., et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29, 2126-2131.
39. Xu, Y., Liu, L., Liu, J., et al. (2011). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128, 412-417.
40. Yanaihara, N., Caplen, N., Bowman, E., et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198.
41. Yuen, M.F., Hou, J.L., and Chutaputti, A. (2009). Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 24, 346-353.
42. Zamore, P.D., and Haley, B. (2005). Ribo-gnome: the big world of small RNAs. Science 309, 1519-1524.
43. Zender, L., Villanueva, A., Tovar, V., et al. (2010). Cancer gene discovery in hepatocellular carcinoma. J Hepatol 52, 921-929.
44. Zeng, Y., and Cullen, B.R. (2003). Sequence requirements for microRNA processing and function in human cells. RNA 9, 112-123.
45. Zeng, Y., Sun, Q.M., Liu, N.N., et al. (2010). Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol 16, 3578-83.
46. Zhou, B., Rao, L., et al. (2010). Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin Chim Acta 411, 1287-1290.